Metabolomics analysis of human plasma reveals decreased production of trimethylamine N‐oxide retards the progression of chronic kidney disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolomics analysis of human plasma reveals decreased production of trimethylamine N‐oxide retards the progression of chronic kidney disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-16
DOI
10.1111/bph.15856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
- (2021) Wenchao Zhang et al. Scientific Reports
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy
- (2020) Jiang-Ping Song et al. Science Translational Medicine
- Gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
- (2020) Kunpeng Wu et al. BLOOD
- 992 VEGETARIAN DIET REDUCES HUMAN GUT MICROBIAL TMAO PRODUCTIVITY THROUGH ALTERATIONS OF GUT MICROBIOME IN PATIENTS WITH CARDIOVASCULAR DISEASE
- (2020) Wei-Kai Wu et al. GASTROENTEROLOGY
- A maternal serum metabolite ratio predicts fetal growth restriction at term
- (2020) Ulla Sovio et al. NATURE MEDICINE
- Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
- (2020) Lisa Dannenberg et al. PHARMACOLOGY & THERAPEUTICS
- ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
- (2020) Elliott Lilley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids
- (2020) Nikos Koundouros et al. CELL
- TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis
- (2020) Luigina Guasti et al. Internal and Emergency Medicine
- Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
- (2020) Brian G. Poll et al. PHYSIOLOGY
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats
- (2020) Marta Gawrys-Kopczynska et al. eLife
- Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis
- (2019) Jason R. Stubbs et al. Clinical Journal of the American Society of Nephrology
- Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK
- (2019) Ying Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trimethylamine N-Oxide Does Not Impact Viability, ROS Production, and Mitochondrial Membrane Potential of Adult Rat Cardiomyocytes
- (2019) Querio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis
- (2019) Meijun Si et al. Science Translational Medicine
- Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
- (2019) Himel Mallick et al. Nature Communications
- Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites
- (2019) David Michonneau et al. Nature Communications
- Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
- (2018) Steve P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metabolomics Research in Chronic Kidney Disease
- (2018) Morgan E. Grams et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- (2018) Yan Xie et al. KIDNEY INTERNATIONAL
- Oxylipin profiling of human plasma reflects the renal dysfunction in uremic patients
- (2018) Da-Yong Hu et al. Metabolomics
- The spectrum of chronic kidney disease in China: a national study based on hospitalized patients from 2010 to 2015
- (2018) Yu-Ming Huang et al. NEPHROLOGY
- Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
- (2018) Manuel Janeiro et al. Nutrients
- An overview of renal metabolomics
- (2017) Sahir Kalim et al. KIDNEY INTERNATIONAL
- Metabolomics for clinical use and research in chronic kidney disease
- (2017) Berthold Hocher et al. Nature Reviews Nephrology
- Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling
- (2017) Bing-Qing Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
- (2017) Eke G. Gruppen et al. Scientific Reports
- MP85-20 METABOLOMICS AND POST-NEPHRECTOMY RENAL FUNCTION PREDICTION
- (2016) Barak Rosenzweig et al. JOURNAL OF UROLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption
- (2016) Muhammed Khairujjaman Mazumder et al. LIFE SCIENCES
- Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study
- (2015) Aki Mafune et al. Clinical and Experimental Nephrology
- A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
- (2013) E. P. Rhee et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevalence of chronic kidney disease in China: a cross-sectional survey
- (2012) Luxia Zhang et al. LANCET
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Metabolomics in the study of kidney diseases
- (2011) Robert H. Weiss et al. Nature Reviews Nephrology
- Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
- (2009) Jun-Yan Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started